Retinoic acid binds to the C2-domain of protein kinase C(alpha)

Wendy F Ochoa1, Alejandro Torrecillas, Ignacio Fita

  • 1Instituto de Biología Molecular de Barcelona (CSIC), Jordi Girona Salgado 18-26, E-08034 Barcelona, Spain.

Biochemistry
|July 23, 2003
PubMed

Insights

All-trans retinoic acid (atRA) binds to the C2-domain of Protein Kinase C alpha (PKCα) at two sites, competing with acidic phospholipids. This reveals a potential mechanism for PKCα activity modulation by atRA.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • Protein Kinase C alpha (PKCα) regulates crucial cellular processes like growth, differentiation, and apoptosis.
  • All-trans retinoic acid (atRA) is known to modulate PKC activity, but the mechanism and binding sites were unclear.

Purpose of the Study:

  • To elucidate the binding mechanism and sites of all-trans retinoic acid (atRA) within the C2-domain of Protein Kinase C alpha (PKCα).
  • To investigate the structural basis for atRA's interaction with PKCα and its potential role in modulating enzyme activity.

Main Methods:

  • Cocrystallization of the PKCα C2-domain with atRA and subsequent X-ray crystallographic analysis at 2.0 Å resolution.
  • Site-directed mutagenesis and [(3)H]-atRA binding assays to confirm binding sites and affinities.

Main Results:

  • atRA binds to the PKCα C2-domain at two distinct locations.
  • One binding site overlaps with the Ca(2+)-binding pocket, where Ca(2+) mediates atRA-protein interactions.
  • The second site involves a conserved lysine-rich cluster in beta-strands 3 and 4.
  • atRA competes with acidic phospholipids for binding to the C2-domain.

Conclusions:

  • atRA binds to the PKCα C2-domain at sites normally occupied by Ca(2+) and acidic phospholipids.
  • This competitive binding suggests a novel mechanism for PKCα activity regulation by atRA.
  • The findings provide structural insights into the interaction between atRA and PKCα.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...